146
Views
7
CrossRef citations to date
0
Altmetric
Case Study

Severe cutaneous reaction to cetuximab with possible association with the use of over-the-counter skin care products in a patient with oropharyngeal cancer

, , , , , & show all
Pages 41-44 | Received 25 Nov 2008, Published online: 01 Mar 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Pol Specenier & Jan B Vermorken. (2013) Cetuximab: its unique place in head and neck cancer treatment. Biologics: Targets and Therapy 7, pages 77-90.
Read now
Pol Specenier & Jan B Vermorken. (2011) Cetuximab in the treatment of squamous cell carcinoma of the head and neck. Expert Review of Anticancer Therapy 11:4, pages 511-524.
Read now

Articles from other publishers (5)

Júlia Kanaan Recuero, Joana Roberta Fitz, Andrea Abe Pereira & Renan Rangel Bonamigo. (2023) EGFR inhibitors: clinical aspects, risk factors and biomarkers for acneiform eruptions and other mucosal and cutaneous adverse effects. Anais Brasileiros de Dermatologia 98:4, pages 429-439.
Crossref
Arman Zereshkian, Alia Thawer, David M. Hwang & Susanna Cheng. (2022) EGFR Targeting TKI-Related Skin Toxicities in a Patient with Darker Skin: A Case Report. Current Oncology 29:4, pages 2509-2515.
Crossref
Amy J. Derick. 2013. Dermatologic Principles and Practice in Oncology. Dermatologic Principles and Practice in Oncology 410 415 .
M Gobbo, G Ottaviani, G Mustacchi, R Di Lenarda & M Biasotto. (2011) Acneiform rash due to epidermal growth factor receptor inhibitors: high-level laser therapy as an innovative approach. Lasers in Medical Science 27:5, pages 1085-1090.
Crossref
Edgar Selzer, Susanne Liederer, Christiane Lemaire, Gerhard Kren, Dejan Radonjic, Gabriela Kornek, Thomas Knocke, Richard P?tter & Barbara Bachtiary. (2011) Incidence of dermatitis in head and neck cancer patients treated with primary radiotherapy and cetuximabInzidenz von Dermatitis bei Patienten mit Tumoren der Kopf-Hals-Region unter einer prim?ren Strahlentherapie in Kombination mit Cetuximab. Strahlentherapie und Onkologie 187:6, pages 373-377.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.